Kingston Clinical Commissioning Group is committed to being an open and transparent organisation. As part of this commitment we publish reports regarding expenditure over £25,000. A copy of this report is available to download on the right hand side of this page.
Kingston CCG currently participates in primary care rebate schemes (PCRS) offered by pharmaceutical companies or third party companies, which have been through our agreed approval process.
These offer financial rebates to the CCG on prescribing expenditure for particular branded medicine(s). The availability of a PCRS does not influence the inclusion of specific medicines in care pathways or formularies.
As of March 2020, Kingston CCG has signed up for the following primary care rebate schemes: